BIOTEST AG VZ/ DE0005227235 /
2024-08-30 5:32:11 PM | Chg. +1.60 | Volume | Bid5:32:11 PM | Ask5:32:11 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
27.10EUR | +6.27% | 375 Turnover: 9,712.50 |
-Bid Size: - | -Ask Size: - | 1.62 bill.EUR | 0.10% | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -1.59 EUR | 103.85% |
EPS Diluted: | -1.59 EUR | 103.85% |
Revenues per Share: | 13.03 EUR | 6.48% |
Book Value per Share: | 9.61 EUR | -13.86% |
Cash Flow per Share: | 0.86 EUR | - |
Dividend per Share: | 0.04 EUR | 0.00% |
Total | in mill. | |
Revenues: | 515.60 EUR | 6.48% |
Net Income: | -63.40 EUR | 101.91% |
Operating Cash Flow: | 33.90 EUR | - |
Cash and Cash Equivalents: | 104.40 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 3.15 | 2.96 |
P/BV ratio: | 4.27 | 4.02 |
P/CF Ratio: | 47.86 | 45.06 |
PEG: | -0.25 | - |
Earnings Yield: | -3.88% | -4.12% |
Dividend Yield: | 0.10% | 0.10% |
Market Capitalization | ||
Market Capitalization: | 1.62 bill. EUR | 1.53 bill. EUR |
Free Float Market Cap.: | 811.23 mill. EUR | 763.74 mill. EUR |
Market Cap. / Employee: | 412,417.8953 EUR | 388,276.3599 EUR |
Shares Outstanding: | 19.79 mill. |
Profitability
Gross Profit Margin: | 15.65% |
EBIT Margin: | -9.14% |
Net Profit Margin: | -12.30% |
Return on Equity: | -16.67% |
Return on Assets: | -5.74% |
Financial Strength
Liquidity I / Cash Ratio: | 98.12% |
Liquidity II / Quick Ratio: | 198.97% |
Liquidity III / Current Ratio: | 490.79% |
Debt / Equity Ratio: | 190.27% |
Dynam. Debt / Equity Ratio: | 2,135.10% |
Efficiency
Employees: | 1,967 |
Personal Expenses / Employee: | 83,019.83 EUR |
Revenues / Employee: | 262,125.06 EUR |
Net Income / Employee: | -32,231.83 EUR |
Total Assets / Employee: | 561,362.48 EUR |
* Fiscal Year End: | 2021-12-31 |
Accounting Standard: | IFRS |
Currency: | EUR |